Literature DB >> 27067591

Worldwide burden of colorectal cancer: a review.

Pasqualino Favoriti1, Gabriele Carbone1, Marco Greco1, Felice Pirozzi2, Raffaele Emmanuele Maria Pirozzi3, Francesco Corcione1.   

Abstract

Colorectal cancer is a major public health problem, being the third most commonly diagnosed cancer and the fourth cause of cancer death worldwide. There is wide variation over time among the different geographic areas due to variable exposure to risk factors, introduction and uptake of screening as well as access to appropriate treatment services. Indeed, a large proportion of the disparities may be attributed to socioeconomic status. Although colorectal cancer continues to be a disease of the developed world, incidence rates have been rising in developing countries. Moreover, the global burden is expected to further increase due to the growth and aging of the population and because of the adoption of westernized behaviors and lifestyle. Colorectal cancer screening has been proven to greatly reduce mortality rates that have declined in many longstanding as well as newly economically developed countries. Statistics on colorectal cancer occurrence are essential to develop targeted strategies that could alleviate the burden of the disease. The aim of this paper is to provide a review of incidence, mortality and survival rates for colorectal cancer as well as their geographic variations and temporal trends.

Entities:  

Keywords:  Colorectal cancer; Epidemiology; Incidence; Mortality

Mesh:

Year:  2016        PMID: 27067591     DOI: 10.1007/s13304-016-0359-y

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  40 in total

1.  Is there a true "shift" to the right colon in the incidence of colorectal cancer?

Authors:  Linda Rabeneck; Jessica A Davila; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864

2.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

3.  Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.

Authors:  Judith Swan; Nancy Breen; Ralph J Coates; Barbara K Rimer; Nancy C Lee
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  Trends in colorectal cancer test use among vulnerable populations in the United States.

Authors:  Carrie N Klabunde; Kathleen A Cronin; Nancy Breen; William R Waldron; Anita H Ambs; Marion R Nadel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-08       Impact factor: 4.254

5.  Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Chyke A Doubeni; Adeyinka O Laiyemo; Jacqueline M Major; Mario Schootman; Min Lian; Yikyung Park; Barry I Graubard; Albert R Hollenbeck; Rashmi Sinha
Journal:  Cancer       Date:  2012-01-03       Impact factor: 6.860

Review 6.  Epidemiology of colorectal cancer.

Authors:  Peter Boyle; Maria Elena Leon
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

7.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

8.  Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer.

Authors:  Arnold L Potosky; Linda C Harlan; Richard S Kaplan; Karen A Johnson; Charles F Lynch
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

9.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Authors:  Milena Sant; Claudia Allemani; Mariano Santaquilani; Arnold Knijn; Francesca Marchesi; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2009-01-24       Impact factor: 9.162

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

View more
  193 in total

1.  Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients.

Authors:  Alban Zarzavadjian Le Bian; Christine Denet; Nicolas Tabchouri; Gianfranco Donatelli; Philippe Wind; Christophe Louvet; Mostefa Bennamoun; Christos Christidis; Thierry Perniceni; David Fuks; Brice Gayet
Journal:  Langenbecks Arch Surg       Date:  2018-04-27       Impact factor: 3.445

2.  Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Yoshimasa Gohda; Kenta Miwa; Kensuke Otani; Tomomichi Kiyomatsu; Hideaki Yano
Journal:  Ann Nucl Med       Date:  2021-05-04       Impact factor: 2.668

3.  miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.

Authors:  Dan Liao; Tong Li; Caiguo Ye; Liuyan Zeng; Huahui Li; Xingxiang Pu; Congcong Ding; Zhiwei He; Guo-Liang Huang
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

4.  Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer.

Authors:  Bingjun Bai; Lina Shan; Binbin Xie; Xuefeng Huang; Weifang Mao; Xiaowei Wang; Da Wang; Hongbo Zhu
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

5.  Suppression of LINC00460 mediated the sensitization of HCT116 cells to ionizing radiation by inhibiting epithelial-mesenchymal transition.

Authors:  Jiani Zhang; Lixin Ding; Gaofeng Sun; Huacheng Ning; Ruixue Huang
Journal:  Toxicol Res (Camb)       Date:  2020-04-24       Impact factor: 3.524

6.  Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach.

Authors:  Chi-Long Chen; Chi-Kuan Chen; Chung-Liang Ho; Wei-Ming Chi; Chien-Hsuan Yeh; Shian-Pin Hu; Peter Friebe; Stuart Palmer; Chin-Shiou Huang
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

7.  GIDB: a knowledge database for the automated curation and multidimensional analysis of molecular signatures in gastrointestinal cancer.

Authors:  Ying Wang; Yueqian Wang; Shuangkuai Wang; Yuantao Tong; Ling Jin; Hui Zong; Rongbin Zheng; Jinxuan Yang; Zeyu Zhang; En Ouyang; Mengyan Zhou; Xiaoyan Zhang
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

8.  Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state.

Authors:  Chaonan Ye; Kun Han; Jinxiu Lei; Kui Zeng; Su Zeng; Haixing Ju; Lushan Yu
Journal:  Br J Pharmacol       Date:  2018-10-04       Impact factor: 8.739

Review 9.  Colorectal resection via natural orifice specimen extraction versus conventional laparoscopic extraction: a meta-analysis with meta-regression.

Authors:  Y H Chin; G M Decruz; C H Ng; H Q M Tan; F Lim; F J Foo; C H Tai; C S Chong
Journal:  Tech Coloproctol       Date:  2020-08-26       Impact factor: 3.781

10.  [Role of aquaporin-5 in regulating colorectal cancer cell growth in vitro].

Authors:  Shuo Chen; Tao Shan; Li Wang; Xi Chen; Xi-Juan Cui; Xian-Ni Gao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.